Helicos Shares Delisted from Nasdaq

The company withdrew its appeal to the Nasdaq after determining its finances and near-term business prospects would make it unlikely that it could meet listing requirements.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.